Evidence map›Paper›PMID 28067885›Full record

ArticleBone marrow transplantation2017

Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization.

D Grosso, E Johnson, B Colombe, O Alpdogan, M Carabasi, J Filicko-O'Hara, S Gaballa, M Kasner, T Klumpp, U Martinez-Outschoorn and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Biology of Disease Relapse in Myeloid Disease: Implication for Strategies to Prevent and Treat Disease Relapse After Stem-Cell Transplantation.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
    Review
  5. Article
  6. Review
  7. Clonal evolution and immune evasion in posttransplantation relapses.Hematology. American Society of Hematology. Education Program · 2019
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

D GrossoDepartment of Hematological Malignancies and Blood and Marrow Transplantation, Division of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
E JohnsonDepartment of Pathology, Thomas Jefferson University, Philadelphia, PA, USA.
B ColombeDepartment of Tissue Typing, Thomas Jefferson University, Philadelphia, PA, USA.
O AlpdoganDepartment of Hematological Malignancies and Blood and Marrow Transplantation, Division of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
M CarabasiDepartment of Hematological Malignancies and Blood and Marrow Transplantation, Division of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
J Filicko-O'HaraDepartment of Hematological Malignancies and Blood and Marrow Transplantation, Division of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
S GaballaDepartment of Hematological Malignancies and Blood and Marrow Transplantation, Division of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
M KasnerDepartment of Hematological Malignancies and Blood and Marrow Transplantation, Division of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
T KlumppDepartment of Hematological Malignancies and Blood and Marrow Transplantation, Division of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
U Martinez-OutschoornDepartment of Hematological Malignancies and Blood and Marrow Transplantation, Division of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
J L WagnerDepartment of Hematological Malignancies and Blood and Marrow Transplantation, Division of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
M WeissDepartment of Hematological Malignancies and Blood and Marrow Transplantation, Division of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
Z WangDepartment of Pathology, Thomas Jefferson University, Philadelphia, PA, USA.
N FlomenbergDepartment of Hematological Malignancies and Blood and Marrow Transplantation, Division of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationTransplantation ConditioningAdultAgedAllograftsChromosomes, Human, Pair 6CyclophosphamideFemaleHumansMaleMiddle AgedCyclophosphamide

Identifiers

PMID28067885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.